We publish only limited public contact methods at launch. If you need to suggest a correction, ask a question about site editorial policy, or offer feedback about the presentation of material, please use the published channels; check our about page for details on editorial contact routes and policies linked below.
For information about the organization and how we work, our editorial statement is available on the site’s about page and can be read at the About page describing our editorial approach.
To verify the clinical trial landscape or related services, readers sometimes consult external registries; for regional trial information see the clinical listing at ibogaine clinical trial listings in Texas .
When you are ready to reach us, please revisit this page for published contact channels; in the meantime, our homepage also links to main resources and topical guides if you wish to continue exploring the site: browse the site's resource hub and featured guides.
Brief notes
Ibogaine Microdosing is an independent information company, not a clinic or medical provider. Its content is not medical or legal advice.
If you are seeking clinical services or immediate medical support, consult verified clinical registries or established medical centers; authoritative overviews of clinical trial registration practices are available through resources like ClinicalTrials.gov and discussions of substance-related safety at reputable public health sites such as the U.S. Centers for Disease Control and Prevention. These are offered as general pointers while we finalize direct contact channels.